Mr. Chau is our Chief Financial Officer (“CFO”). He joined Regencell Bioscience Limited in January 2021. Mr. Chau brings over 15 years of finance experience. Mr. Chau’s CFO experience include four mainboard listed companies on the Hong Kong Stock Exchange and one mainboard listed company on the Tokyo Stock Exchange. He also brings extensive treasury and risk management experience. Mr. Chau was Philips’ Asia Head of Cash Management and Risk and IBM’s China Treasurer.

Prior to joining IBM, Mr. Chau worked at Merrill Lynch and Booz Allen & Hamilton where he gained investment banking, capital markets and management consulting experience.

Mr. Chau obtained his Bachelor’s degree in finance from the University of Texas at Austin with the highest honor and obtained his MBA from Massachusetts Institute of Technology.